NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 2,275.00
+278.00 (13.92%)
At close: Aug 11, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 20.33 billion as of August 12, 2026. Its market cap has decreased by -58.10% in one year.
Market Cap
20.33B
Enterprise Value
46.15B
Revenue
31.20B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,275.00
ChartMarket Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 20.33B, a decrease of -93.51%. That is a compound annual growth rate of -38.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 20.33B | -44.38% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.24% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Progen | 42.20B |
| HLB Pep | 42.19B |
| Quratis | 38.65B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 34.60B |
| Poongjeon Pharmacy CO.,LTD. | 23.34B |
| Shaperon | 21.60B |